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Abstract 
LED light technology is used in this pilot study to demonstrate the ability to create a cost 
effective light apparatus using 1-watt LEDs with wavelengths of 740nm,850nm, and 940nm to 
test for an increased insulin response using porcine islet of Langerhans cells. This is building on 
recent research showing increased insulin response in rat islet cells when exposed to LED light. 
However, due to the high variance and low sample size, statistically significant changes were not 
measured when irradiating cells with 740nm, 850nm, and 940nm LED light using 7.9 J/cm2 and 
15.8 J/cm2 dosages along with low and high glucose conditions. There are however possible 
trends of increased insulin secretion that may become significant with increased sample size. 
There is a need to repeat this study to definitively determine if increased insulin secretion does 
occur in porcine islet of Langerhans cells along with any potential negative effects and what the 
optimal wavelengths and dosages would be. Using the cost effective light apparatus, additional 
wavelengths can be experimented with to cover between 300nm to over 1600nms. The 
information garnered from this research has the potential to improve islet of Langerhans cell 
transplantation for type one diabetes (T1D) patients by decreasing the number of cells needed to 
be therapeutic and increasing insulin release.  
Introduction 
Many portions of the electromagnetic spectrum are harnessed by humankind for an 
extensive range of beneficial applications. Some of the most notable examples are cell phone 
signals, microwave ovens, light emitting diodes (LED), radiographs, diagnostic ultrasound 
machines, CT scanning machines, and MRI machines. LED light technology, in particular, is 
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currently in a pioneering stage with light output efficiency doubling every 18-24 months since 
1968.1 This has allowed economy of scale and reduced cost to reach scientists for 
experimentation.2  Some current notable uses of LED lighting for medical treatment include 
using light for skin disorders,3 seasonal depression,4 circadian rhythm sleep disorders,5 and 
neonatal jaundice.6  Physical therapists have been using the technology to help with tissue 
healing,7-12 pain management,13-17 and treating joint disorders.18-20 
There is considerable research interest in this field for the treatment of medical conditions 
either as an adjunct to medication or on its own. For example, light irradiation has been shown 
effective in stimulating protein release from secretory cells such as mast cells,21-22 
macrophages,23 keratinocytes,24 thymus cells,25 smooth muscle cells, fibroblasts, and 
cardiomyocytes.26 Islet of Langerhans are clusters of cells found in the pancreas. They contain 
beta cells which produce insulin to regulate blood glucose in the human body. Light irradiation 
has recently been shown to improve islet function in rats using red light (630nm) or infrared light 
(810nm) to significantly increase insulin secretion after glucose challenge tests.27,28 This 
information suggests the possibility for light therapy to aide in type one diabetes (T1D) 
treatment.  
According to the CDC’s Diabetes Report Card and National Diabetes Statistics Report, 
nearly 208,000 people have T1D under the age of 20 as of 2014.29 T1D results from the pt.’s 
body destroying its own insulin secreting cells contained in the islets of Langerhans. One 
promising experimental treatment under current investigation is islet transplantation. By 
receiving healthy insulin producing islet cells from a donor(s), T1D patients may no longer need 
insulin injections.30-33 However, there are still significant challenges preventing this treatment 
method from changing over from an experimental procedure.30,34-38 The most notable challenges 
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are the loss of healthy islets after transplantation caused by an autoimmune response from the 
recipient, the shortage of organ donors, and the need for two deceased human pancreases to 
obtain enough islets to achieve a normal glycemic level for one T1D patient.36,39 
New LED technology could be used to benefit type one diabetes patients and this 
evolving new medical procedure. Low intensity infrared light modulation of biological processes 
of the human body is coined photobiomodulation.  The wavelength of light used affects the depth 
of tissue penetration and ultimately the cellular effects.40 Light with a longer wavelength 
penetrates deeper than light with a shorter wavelength.41,42 Currently, there is relatively little 
research on photobiomodulation using infrared light to evoke an insulin response from islet of 
Langerhans cells.  
The purpose of this research is to perform a pilot study to demonstrate how to cost 
effectively construct a 1-watt LED light apparatus and to determine if light at wavelength of 
740nm, 840nm, and 940nm is able to evoke an insulin secretion response from isolated porcine 
islet of Langerhans cells.  
Methodology 
Research Design 
The research design chosen for this project was a pilot study format. The reasons are to 
test for feasibility of designing an LED light apparatus along with modifying existing islet 
isolation and irradiation protocols for porcine islets. This pilot study should justify expanding 
research.  
Materials  
Tools: Hot glue gun, Soldering gun, Scissors, Wire striper and cutter, 
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Materials to construct LED light Base: Retort stand with ring clamp, 4mm thick opaque plastic 
4” by 4” sheet 
Materials to construct LED light: LED driver model Chihui CH031 with specifications (LED 
driver specifications: input AC 85V- 255V at 50/60 Hz, output: constant current 320mA DC 2.5-
12V), 1 LED 940nm 1-watt infrared, 1 LED 850nm 1-watt infrared, 2 LED 760nm 1-watt red, 1 
6ft IEC power cord, Velcro 6” by 4” cut to fit, 4 pairs of 22AWG Wire JST SM 2P Connectors 
Male and Female, and 6 feet of 24 AWG two conductor power wire. 
Bonding materials needed: All purpose hot glue sticks, 6 inch zip ties, Solder spool, and 
Electrical tape.  
Note: All LED parts were purchased from EBay. The remaining materials can be purchased 
online or from a big box home supply store. 
Procedures 
Constructing LED light apparatus 
First, acquire all materials and tools needed to construct the LED light system and gather 
them to a suitable working site such as a table top. Begin by making the detachable experimental 
LEDs. First, Solder the red (+) and black (-) wires from the JST SM 2P female connector to the 
(+) and (-) labeled soldering points on the LED using the soldering gun. Next, wrap the soldered 
wires around to the bottom of the LED base and attach using hot glue. From there, cut out 
Velcro, hook surface side, into a donut shape and affix to the top of the LED surface leaving a 
hole just large enough for the LED to pass through. The Velcro comes with an adhesive backing 
that can be further secured using some hot glue. See Figure 1-2 Repeat this procedure to 
complete each wavelength LED. There should be a 740nm, 850nm, and 940nm LED when 







To begin constructing the light base retrieve the retort stand and base and secure the LED driver 
to the stand using zip ties. Next, take the opaque plastic sheet and use the scissors to modify the 
sheet to the size of the ring portion of the stand. Attach the plastic 
sheet using hot glue. Finish by cutting a 1cm diameter hole in the middle of the plastic sheet. 
Next cut out loop side Velcro and attach it to the bottom surface of the plastic sheet around the 
hole without covering it. This will be where the exchangeable LEDs will be attached and 
removed. The petri dishes sit on top of the opaque plastic sheet centered to the LED to irradiate 
the cells.  
The last portion of the build is to wire the LED light apparatus. First, take the 6 ft. IEC 
power cord and cut the female plug off. There should be 3 wires exposed (black, red, green). 
Next, cut away the green wire and then strip back ½” of the copper wire sheathing from the red 
and black wire. Twist the red exposed wire from the 6 ft. power cable to one of the two power 
input wires from the LED driver. It does not matter which wire. Solder the wire to secure in 
place. Now, wrap newly soldered wire with electrical tape. Next, twist the black exposed wire 
from the 6 ft. power cable to the second of two power input wires from the LED driver. Solder 
the twisted black and power input LED driver wires together. Wrap the newly soldered wire with 
electrical tape. The LED driver should now have a power cord attached to it. See figure 3. The 
Figure 1. Front LED exchange bulb light 
Figure 2. Back LED exchange bulb light 
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last portion of the wiring completes the quick connector for changing the LEDs and an indicator 
LED to inform the experimenter that the apparatus is on or off. First, wire a male SM 2P quick  
connector and 760nm red LED in series with enough wire to place the red LED at the bottom of 
the light apparatus along with enough wire to attach and remove different wavelengths of 
experimental LEDs to the light Velcro base constructed through a JST SM 2P male connector. 
The wire should begin with the positive LED driver output wire attached to additional wire for 
length. Following the wire should connect to the positive end of the JST SM 2P male connector. 
The wire loop continues down the black (-) wire of the JST SM 2P male connector to additional 
wire for length. From there, the wire should continue to the positive terminal of the red 740nm 
LED. A second wire should then connect to the negative terminal of the same 740nm red LED. 
This wire should end by attaching to the negative output wire of the LED driver completing the 
loop. Each connection of wire should be connected by stripping the insulation ¼” back and 
soldering the connections. End with insulating each connection by wrapping with electrical tape. 
See completed apparatus in figure 4. 
 
 
Figure 4.  Showing the completed LED apparatus 
within an incubation chamber 
Figure 3. Finished attaching power 
cord to LED driver 
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Harvesting and isolating Porcine pancreas islet of Langerhans cells 
Porcine pancreas tissue was isolated from animals harvested for food and fiber education 
research. For this pilot study, five pig donors were harvested humanely according to the United 
States Department of Agriculture (USDA) guidelines at ASU’s Food Safety and Product 
Development Laboratory. The tissue samples were collected individually with the warm 
ischemia time, the time between the cessation of the heart beating and the placement of the 
pancreas tissue into the preservation solution, was within 30 minutes. The pancreas tissue was 
stored in 4 ⁰C Belzer UW Cold storage solution and transported on ice to ASU’s Diabetes 
Research Lab for islet isolation. The cold ischemia time, the time between the placement of the 
pancreas into the Belzer UW Cold Storage solution and the start of islet isolation, was within 2 
hours. Islet isolation was conducted using a modified Ricordi method.43 The main components of 
the isolation were soaking the pancreas tissue in a solution of Liberase DL (1.0 mg/mL; Sigma-
Aldrich) and letting it digest in a sterilized 37 ⁰C incubation chamber for 20-30 minutes with 
occasional gentle shaking. The digested tissue was then collected into RPMI-1640 medium with 
10% fetal bovine serum (FBS) and washed twice to remove the digestive enzyme. The islets 
were then purified by using a continuous density gradient based on a modified protocol.44 The 
islets were then extracted and placed into RPMI-1640 with 10% porcine serum and 1% 
antibiotic/antimycotic and put into a 37 ⁰C culture chamber containing 5% CO2. The now 
isolated islet of Langerhans cells were then left to rest for 24 hours before being submitted to the 
light and glucose trials. 
LED light irradiation on islets 
The isles were transferred into a 24-well plate with low (3mM) or high (16.7 mM) glucose and 
subjected to a 1-watt LED light with a wavelength of either 740nm, 850nm, or 940nm for 15 
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seconds (7.9 J/cm2) or 30 seconds (15.8 J/cm2) in a 37 ⁰C incubator. After a 60-minute 
incubation period, the supernatant was collected and frozen at -80 ⁰C. The samples were then 
analyzed by an insulin enzyme-linked immunosorbent assay (ELISA) test kit to measure insulin 
secretion. 
Statistical Analysis 
The samples were compared to the control using one-way ANOVA statistical analysis 
Results 
The raw data was compiled and organized into tables 1-3 The data for Tables 2 and 3 
were normalized by comparing insulin secretion to total protein content by a relative fold change 
using the control sample. Each sample contained a minimum of 100 islets. Table 1 shows the 
change in insulin secretion in response to no LED irradiation and LED irradiation for one 
porcine subject. The data shows that low dose light (7.9 J/cm2) increased insulin production 
under high glucose while the high dose light (15.8 J/cm2) increased insulin production under the 

















































































Table 1. Insulin secretion after light irradiation (1-Watt 740nm LED). Two different doses were applied for 





For the next portion of the study, islet from five pigs were treated by three different 
wavelength 1-watt LEDs (740nm, 850nm, and 940nm) under 3.0mM and 16.7mM glucose seen 
in Table 2. When compared to the controls that received no light irradiation insulin secretion 
under low glucose light irradiation, Table 2a, increased 27% using 740nm and 9% using 850nm. 
Using 940nm light irradiation insulin secretion decreased 9%. In Table 2b high glucose, light 
irradiation using 740nm increased insulin secretion 36%, but decreased 38% under 850nm and 
30% under 840nm. Overall, the differences were not statistically significant due to small sample 









































































































Table 2. Insulin secretion after light irradiation with a dose of 15.8 J/cm2 under low and high glucose. N 
= 5 trials in each group. Each trial contained at least 100 islets from one pig. The expressions in each 
group are presented as relative fold difference to the control group. The left portion of the table is 2a and 
the table to the right is 2b. 
 
In Table 3, at 740nm light irradiation under low glucose (3.0mM) there is a possible 
upward trend in insulin secretion relative to the control. With a 7.9 J/cm2 dose there is a 19% 
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increase in insulin secretion relative to the control and a 27% increase at the 15.8 J/cm2 dosage 
level. When the islets were bathed in high glucose (16.7mM), the 7.9 J/cm2 dose showed a 2% 
increase in insulin secretion while the 15.8 J/cm2 dose showed a 36% increase in insulin 
secretion relative to the control. At 850nm light irradiation under low glucose (3.0mM) the 7.9 
J/cm2 dose shows a 10% increase in insulin secretion relative to the control and a 9% increase at 
the 15.8 J/cm2 dosage level. When the islets were bathed in high glucose (16.7mM) the 7.9 J/cm2 
dose showed a 28% decrease in insulin secretion while the 15.8 J/cm2 dose showed a 38% 
decrease in insulin secretion relative to the control. At 940nm light irradiation under low glucose 
(3.0mM) the 7.9 J/cm2 dose shows a 2% decrease in insulin secretion relative to the control and a 
9% decrease at the 15.8 J/cm2 dosage level. The standard error is 43%. When the islets were 
bathed in high glucose (16.7mM) the 7.9 J/cm2 dose showed a 58% decrease in insulin secretion 







































































































































































































































































































































Table 3. Insulin secretion response using three different wavelengths and two different doses of LED 
irradiation in addition to low or high glucose conditions. N = 5 trials in each group. Each trial 
contained at least 100 islets from one pig. The expressions in each group are presented as relative fold 





The purpose of this pilot study is to demonstrate the ability to construct a cost effective 
LED light apparatus and to create a modified porcine islet of Langerhans protocol to measure 
insulin secretion while modify light wavelength, light dosage, and glucose environment. The 
results of the pilot study do show a possible insulin secretion change that appears dependent on 
the light dose, and light wavelength. At 740nm of light, increasing light dosage shows a possible 
upward trend in insulin secretion under the low and high glucose environment. Also, when the 
wavelength of light changed to 850nm there is a possible upward insulin secretion trend with 
increasing light dosage in the low glucose environment. However, in the high glucose 
environment there is a possible downward trend of insulin secretion.  Finally, the 940nm light 
shows a possible downward trend under low and high glucose environments. Overall, the insulin 
trends for all the results were not statistically significant due to high variation and small sample 
size. The pilot study does prove, however, that a modified islet isolation technique created for 
porcine tissue along with creating an LED light to test wavelengths and dosage does produce 
viable results to continue further research. By expanding the light wavelengths and dosages 
along with increasing sample size, the optimal wavelength and dosage can be discovered.  Also 
the pilot study suggests there is the possibility of light irradiation creating an adverse effect in 
decreasing insulin secretion or causing cell death. Further research can discover potential 
wavelength and dosages to be avoided in the future using the experimentation methods created in 
this pilot study.  
LED light technology is currently being used by physical therapists in the clinic for tissue 
healing 7-12 and pain management.13-17 The equipment in the clinic most commonly uses light 
with wavelengths between 600 nm and 1300nm due to its optimal depth of penetration in human 
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tissue.45,46 The equipment however is not specific enough for this experimentation because the 
wavelengths emitted are designed to deliver a broad wavelength range by using a mix of 
different LEDs.47  LED equipment irradiating narrow bandwidths that could be used in 
experimentation to determine the most effective bandwidth and dosage for islet insulin 
production does not cheaply exist. The LED apparatus designed and created for this experiment 
costs under 40 dollars in parts and can be assembled in under 3 hours. In addition, the light 
apparatus is designed to quickly switch LEDs to experiment with narrow bandwidths from 
300nm to above 1600nm. In addition, there is a second LED indicator built into the apparatus to 
provide visual real-time feedback to the experimenter when the light is on and that the LED used 
for the experiment is indeed functional. This is a cost effective indicator that serves as a check 
system to maintain high confidence that the apparatus is functional. If the LED being used for 
the experiment was non-functional then it would be indicated by the second visual check LED 
remaining unlit. For this experiment 740nm, 850nm, and 940nm 1-watt LEDs were used but 
could be expanded to cover 300nm to beyond 1600nm to determine the optimal dosage and 
wavelengths for insulin secretion.  
Overall, the information discovered by expanding this research can be applied to the 
medical field through T1D islet transplantation research. Currently T1D patients receive insulin 
injections or an insulin pump to control their condition.48 In extreme cases a T1D patient may 
receive a pancreas transplant if they are unable to control their glucose levels.49 The problems 
with traditional transplantation are the complications and risks associated with major surgery. A 
viable minimally invasive procedure would lower the risk and create a more widely available 
choice for T1D patients. The most notable challenges for islet transplantation treatment at this 
time are the loss of healthy islets after transplantation caused by an autoimmune response, the 
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shortage of organ donors, inadequacy of vascularization or low oxygen tension in the liver, and 
the need for two deceased human pancreases to obtain enough islets to achieve a normal 
glycemic level 23.36,39 Given the limits at this time, there are several original approaches to 
overcome these challenges. To address the autoimmune response, researchers are attempting to 
encapsulate islets through extravascular macrocapsulation and microencapsulation to prevent 
immune destruction after transplantation.32,33 To address low vascularization/oxygenation, 
researchers are exploring transplanting islets to alternative sites such as the greater omentum, or 
intramuscular and subcutaneous spaces.34,36 Finally, to minimize the need for additional islet 
tissue, LED irradiation treatment using optimal dosage and wavelength research can be used to 
increase insulin production of islets to reduce the number of islets needed for a successful 
transplantation. Light therapy has been demonstrated to penetrate tissue to a depth between a few 
millimeters to 50 millimeters, which is dependent on the wavelength applied.41,42 Light protocols 
could be developed to irradiate islets located in the greater omentum or subcutaneous tissue to 
stimulate an increased insulin response. The outcomes of this research as an adjunct to the 
overall transplantation procedure could help transition it from experimental to a minimally 
invasive paid treatment in the near future.  
Some potential areas of improvement on this pilot study design would be better control of 
the variation on tissue harvesting; specifically, the animal’s gender may be a contributing 
variable to the variation seen between subjects.  Also, increasing the sample size with additional 
funding could have produced a statistical change in insulin response and increased the validity of 






LED light technology has been shown to increase islet insulin secretion in rats. This pilot 
study demonstrates the ability to create a cost effective experimental light apparatus to test 
dosage and wavelength of LED light from 300nm to 1600nm along with a modified islet 
isolation protocol for porcine pancreatic tissue. The pilot study was able to demonstrate the 
feasibility of the research protocol and show a potential trend in stimulating an increased insulin 
response using porcine islets. However, due to the high variance and low sample size, 
statistically significant changes were not measured when irradiating cells with 740nm, 850nm, 
and 940nm LED light using 7.9 J/cm2 and 15.8 J/cm2 dosages and low and high glucose 
conditions. There is a need to repeat this study to definitely determine if increased insulin 
secretion does occur in porcine islet of Langerhans cells and what the optimal wavelengths and 
dosages would be. This information has the potential to improve islet of Langerhans cell 
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